Objective: A stakeholder group for persons living with dementia (PLWD) was convened to support the work of a major US dementia research meeting. The objectives of this examination are to present the steps used to implement the Group and guidance for both PLWD and researchers for partnering on research conference planning and participation.

Methods: PLWD met monthly to provide input into the agenda for the 2017 Research Summit on Dementia Care and some Group members also presented at the Summit. Following the Summit, the Group reviewed their contributions and completed an evaluation of the Group process, identifying best practices to support future efforts.

Results: Group members were initially unsure about participating due to concerns about ability to contribute and concerns about disease progression. Members reported that participation was a positive experience, however, identifying Group-led governance and attention to Group work process as important contributors. In addition to giving input to the Summit and having the opportunity to interact with researchers, sharing personal experiences with each other was part of the value of the Group to members. Careful Group selection and attention to governance were among the Best Practices members.

Conclusion: Despite initial uncertainty among members about participating as a Stakeholder Group to inform a national research meeting, members developed a successful process for governance, convening, and providing input to a major national research meeting. Group's self-evaluation yielded specific strategies likely to be useful in formation and implementation of future partnerships between researchers and persons living with dementia.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jagp.2019.10.015DOI Listing

Publication Analysis

Top Keywords

persons living
12
living dementia
12
group members
12
group
10
dementia meeting
8
stakeholder group
8
best practices
8
national meeting
8
dementia
7
members
6

Similar Publications

Biomarkers.

Alzheimers Dement

December 2024

Cognitive Neuroscience Centre, University of San Andres, Victoria, Buenos Aires, Argentina.

Background: Dementia impacts the way individuals perceive and describe everyday events. Alzheimer's disease (AD) notably affects processing of entities manifested by nouns, while behavioral variant frontotemporal dementia (bvFTD) often presents a detached, third-person perspective. Yet, the potential of natural language processing tools (NLP) to detect these variations in spontaneous speech remains explored.

View Article and Find Full Text PDF

Background: Remote diagnostic assessment of cognitively impaired individuals offers numerous potential benefits including increased access to care. However, remote cognitive and behavioral assessment also has limitations, and may not be appropriate for certain patients. Currently, evidence-based guidance on virtual assessment readiness is lacking.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.

Background: Behavioural changes are among the first symptoms noticeable to the person themselves as they begin to experience cognitive decline. Blood-based biomarkers could potentially be a less invasive and easily detectable biomarker for early identification of Alzheimer's disease and dementia. However, the contributions and pathobiology of blood biomarkers to disease trajectory and prevalence in Asians requires further definition.

View Article and Find Full Text PDF

Background: Approximately 6.7 million Americans, aged 65 and older, are living with Alzheimer's disease (AD) dementia. Ethnoracial minority populations are at greater risk for AD.

View Article and Find Full Text PDF

Background: Microglial activation is an early phenomenon in Alzheimer's disease (AD) that may occur prior to and independently of amyloid-β (Aβ) aggregation. Compelling experimental evidence suggests that the apolipoprotein E ε4 (APOEε4) allele may be a culprit of early microglial activation in AD. However, it is unclear whether the APOEε4 genotype is associated with microglial reactivity in the living human brain.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!